SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl

Jing Chen, Wen Mei Yu, Hanako Daino, Hal Broxmeyer, Brian J. Druker, Cheng Kui Qu

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

SHP-2 phosphatase forms a stable protein complex with and is heavily tyrosine-phosphorylated by the oncogenic tyrosine kinase Bcr-Abl. However, the role of SHP-2 in Bcr-Abl-mediated leukemogenesis is unclear. In the present report, we provide evidence that SHP-2 is required for hematopoietic cell transformation by Bcr-Abl. In vitro biological effects of Bcr-Abl transduction were diminished in SHP-2Δ/Δ hematopoietic cells, and the leukemic potential of Bcr-Abl-transduced SHP-2Δ/Δ cells in recipient animals was compromised. Further analyses showed that Bcr-Abl protein (p210) was degraded, and its oncogenic signaling was greatly decreased in SHP-2Δ/Δ cells. Treatment with proteasome inhibitors or reintroduction of SHP-2 restored p210 level in Bcr-Abl-transduced SHP-2 Δ/Δ cells. Subsequent investigation revealed that SHP-2 interacted with heat shock protein 90, an important chaperone protein protecting p210 fromproteasome-mediated degradation. The role of SHP-2 in the stability of p210 is independent of its catalytic activity. Blockade of SHP-2 expression in p210-expressing cells by antisense or small-interfering RNA approaches decreased p210 level, causing cell death. Inhibition of SHP-2 enzymatic activity by overexpression of catalytically inactive SHP-2 mutant did not destabilize p210 but enhanced serum starvation-induced apoptosis, suggesting that SHP-2 also plays an important role in downstream signaling of p210 kinase. These studies identified a novel function of SHP-2 and suggest that SHP-2 might be a useful target for controlling Bcr-Abl-positive leukemias.

Original languageEnglish
Pages (from-to)778-785
Number of pages8
JournalBlood
Volume109
Issue number2
DOIs
StatePublished - Jan 15 2007

Fingerprint

Phosphoric Monoester Hydrolases
bcr-abl Fusion Proteins
HSP90 Heat-Shock Proteins
Proteins
Proteasome Inhibitors
Cell death
Small Interfering RNA
Tyrosine
Catalyst activity
Animals
Phosphotransferases
Apoptosis
Degradation
Starvation
Leukemia
Cell Death
Serum

ASJC Scopus subject areas

  • Hematology

Cite this

SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl. / Chen, Jing; Yu, Wen Mei; Daino, Hanako; Broxmeyer, Hal; Druker, Brian J.; Qu, Cheng Kui.

In: Blood, Vol. 109, No. 2, 15.01.2007, p. 778-785.

Research output: Contribution to journalArticle

Chen, Jing ; Yu, Wen Mei ; Daino, Hanako ; Broxmeyer, Hal ; Druker, Brian J. ; Qu, Cheng Kui. / SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl. In: Blood. 2007 ; Vol. 109, No. 2. pp. 778-785.
@article{3676a0916b624e78b03cab8106a5ec73,
title = "SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl",
abstract = "SHP-2 phosphatase forms a stable protein complex with and is heavily tyrosine-phosphorylated by the oncogenic tyrosine kinase Bcr-Abl. However, the role of SHP-2 in Bcr-Abl-mediated leukemogenesis is unclear. In the present report, we provide evidence that SHP-2 is required for hematopoietic cell transformation by Bcr-Abl. In vitro biological effects of Bcr-Abl transduction were diminished in SHP-2Δ/Δ hematopoietic cells, and the leukemic potential of Bcr-Abl-transduced SHP-2Δ/Δ cells in recipient animals was compromised. Further analyses showed that Bcr-Abl protein (p210) was degraded, and its oncogenic signaling was greatly decreased in SHP-2Δ/Δ cells. Treatment with proteasome inhibitors or reintroduction of SHP-2 restored p210 level in Bcr-Abl-transduced SHP-2 Δ/Δ cells. Subsequent investigation revealed that SHP-2 interacted with heat shock protein 90, an important chaperone protein protecting p210 fromproteasome-mediated degradation. The role of SHP-2 in the stability of p210 is independent of its catalytic activity. Blockade of SHP-2 expression in p210-expressing cells by antisense or small-interfering RNA approaches decreased p210 level, causing cell death. Inhibition of SHP-2 enzymatic activity by overexpression of catalytically inactive SHP-2 mutant did not destabilize p210 but enhanced serum starvation-induced apoptosis, suggesting that SHP-2 also plays an important role in downstream signaling of p210 kinase. These studies identified a novel function of SHP-2 and suggest that SHP-2 might be a useful target for controlling Bcr-Abl-positive leukemias.",
author = "Jing Chen and Yu, {Wen Mei} and Hanako Daino and Hal Broxmeyer and Druker, {Brian J.} and Qu, {Cheng Kui}",
year = "2007",
month = "1",
day = "15",
doi = "10.1182/blood-2006-04-019141",
language = "English",
volume = "109",
pages = "778--785",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "2",

}

TY - JOUR

T1 - SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl

AU - Chen, Jing

AU - Yu, Wen Mei

AU - Daino, Hanako

AU - Broxmeyer, Hal

AU - Druker, Brian J.

AU - Qu, Cheng Kui

PY - 2007/1/15

Y1 - 2007/1/15

N2 - SHP-2 phosphatase forms a stable protein complex with and is heavily tyrosine-phosphorylated by the oncogenic tyrosine kinase Bcr-Abl. However, the role of SHP-2 in Bcr-Abl-mediated leukemogenesis is unclear. In the present report, we provide evidence that SHP-2 is required for hematopoietic cell transformation by Bcr-Abl. In vitro biological effects of Bcr-Abl transduction were diminished in SHP-2Δ/Δ hematopoietic cells, and the leukemic potential of Bcr-Abl-transduced SHP-2Δ/Δ cells in recipient animals was compromised. Further analyses showed that Bcr-Abl protein (p210) was degraded, and its oncogenic signaling was greatly decreased in SHP-2Δ/Δ cells. Treatment with proteasome inhibitors or reintroduction of SHP-2 restored p210 level in Bcr-Abl-transduced SHP-2 Δ/Δ cells. Subsequent investigation revealed that SHP-2 interacted with heat shock protein 90, an important chaperone protein protecting p210 fromproteasome-mediated degradation. The role of SHP-2 in the stability of p210 is independent of its catalytic activity. Blockade of SHP-2 expression in p210-expressing cells by antisense or small-interfering RNA approaches decreased p210 level, causing cell death. Inhibition of SHP-2 enzymatic activity by overexpression of catalytically inactive SHP-2 mutant did not destabilize p210 but enhanced serum starvation-induced apoptosis, suggesting that SHP-2 also plays an important role in downstream signaling of p210 kinase. These studies identified a novel function of SHP-2 and suggest that SHP-2 might be a useful target for controlling Bcr-Abl-positive leukemias.

AB - SHP-2 phosphatase forms a stable protein complex with and is heavily tyrosine-phosphorylated by the oncogenic tyrosine kinase Bcr-Abl. However, the role of SHP-2 in Bcr-Abl-mediated leukemogenesis is unclear. In the present report, we provide evidence that SHP-2 is required for hematopoietic cell transformation by Bcr-Abl. In vitro biological effects of Bcr-Abl transduction were diminished in SHP-2Δ/Δ hematopoietic cells, and the leukemic potential of Bcr-Abl-transduced SHP-2Δ/Δ cells in recipient animals was compromised. Further analyses showed that Bcr-Abl protein (p210) was degraded, and its oncogenic signaling was greatly decreased in SHP-2Δ/Δ cells. Treatment with proteasome inhibitors or reintroduction of SHP-2 restored p210 level in Bcr-Abl-transduced SHP-2 Δ/Δ cells. Subsequent investigation revealed that SHP-2 interacted with heat shock protein 90, an important chaperone protein protecting p210 fromproteasome-mediated degradation. The role of SHP-2 in the stability of p210 is independent of its catalytic activity. Blockade of SHP-2 expression in p210-expressing cells by antisense or small-interfering RNA approaches decreased p210 level, causing cell death. Inhibition of SHP-2 enzymatic activity by overexpression of catalytically inactive SHP-2 mutant did not destabilize p210 but enhanced serum starvation-induced apoptosis, suggesting that SHP-2 also plays an important role in downstream signaling of p210 kinase. These studies identified a novel function of SHP-2 and suggest that SHP-2 might be a useful target for controlling Bcr-Abl-positive leukemias.

UR - http://www.scopus.com/inward/record.url?scp=33846223147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846223147&partnerID=8YFLogxK

U2 - 10.1182/blood-2006-04-019141

DO - 10.1182/blood-2006-04-019141

M3 - Article

VL - 109

SP - 778

EP - 785

JO - Blood

JF - Blood

SN - 0006-4971

IS - 2

ER -